articles about African Swine Fever in Press releases

A global scientific consortium which set out to control two major livestock virus epidemics in Europe is celebrating five years of research findings.

Backed by Horizon Europe and led by HIPRA, the 4-year project bets on the potential of live attenuated vaccines to develop an effective, enduring, and secure solution against ASF virus, contributing to animal welfare, global economic stability, and rural communities.

APHIS is asking producers and pig owners to join in efforts to stand vigilant against this disease.

The new Center on Vaccine Evaluation and Alternatives for Antimicrobials, or CVEAA, will support animal vaccine development and usage.

This project will define the stability of ASFV in soybean products commonly imported into the US and improve diagnostic capabilities and surveillance tools.

There are four sessions, one each day Feb. 20-23, at different locations, all starting at 1 p.m. All are free.

One of the world’s largest animal health companies non-exclusively licensed the USDA and UConn’s jointly owned vaccine candidate for African swine fever.

The Foundation for Food & Agriculture Research recently awarded a grant to the USDA and to Kansas State University to develop vaccines for ASFV.

Join USDA all week to learn more about what APHIS is doing, and what you can do, to Protect our Pigs.

Experts presented tools to ensure Brazil remains an African Swine Fever (ASF) - free country.